NDC 0615-8262

bupropion

Bupropion Hydrochloride

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Ncs Healthcare Of Ky, Inc Dba Vangard Labs. The primary component is Bupropion Hydrochloride.

Product ID0615-8262_963b64fa-4431-41c0-b43b-b6e3e47d0b5c
NDC0615-8262
Product TypeHuman Prescription Drug
Proprietary Namebupropion
Generic NameBupropion Hydrochloride
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2014-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA202304
Labeler NameNCS HealthCare of KY, Inc dba Vangard Labs
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0615-8262-39

30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-8262-39)
Marketing Start Date2019-01-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0615-8262-39 [00615826239]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA202304
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-01-08

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:c5a0636b-229e-45ae-8f2c-50bb21f56d25
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993518
  • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]
    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    NDC Crossover Matching brand name "bupropion" or generic name "Bupropion Hydrochloride"

    NDCBrand NameGeneric Name
    68001-264bupropionbupropion
    68382-353bupropionbupropion
    68382-354bupropionbupropion
    68788-7249bupropionbupropion
    68788-9255bupropionbupropion
    70518-1644bupropionbupropion
    71335-0801bupropionbupropion
    71335-0785bupropionbupropion
    0615-8262bupropionbupropion
    43547-288bupropionbupropion
    43547-289bupropionbupropion
    43547-290bupropionbupropion
    50090-3854bupropionbupropion
    50436-0289bupropionbupropion
    55700-644bupropionbupropion
    63187-521bupropionbupropion
    65841-780bupropionbupropion
    65841-836bupropionbupropion
    70934-151bupropionbupropion
    63629-8036bupropionbupropion
    68788-7283bupropionbupropion
    68071-5214bupropionbupropion
    70518-2641bupropionbupropion
    51655-357bupropionbupropion
    71335-1622bupropionbupropion
    0115-5445Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0115-6811Bupropion HydrochlorideBUPROPION HYDROCHLORIDE
    0185-0410Bupropion HydrochlorideBupropion Hydrochloride
    0185-0415Bupropion HydrochlorideBupropion Hydrochloride
    0185-1111Bupropion HydrochlorideBupropion Hydrochloride
    0173-0135WELLBUTRINbupropion hydrochloride
    0173-0722WELLBUTRINbupropion hydrochloride
    0173-0947WELLBUTRINbupropion hydrochloride
    0173-0556ZYBANbupropion hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.